Mcl-1 blocks radiation-induced apoptosis and inhibits clonogenic cell death

Hans Skvara1, Christiane Thallinger, Volker Wacheck

  • 1Department of Radiotherapy and Radiobiology, University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria.

Anticancer Research
|August 6, 2005
PubMed
Abstract

Insights

Mcl-1 (myeloid cell leukemia 1) protein expression increases radioresistance in human melanoma cells. Down-regulating Mcl-1 with antisense oligonucleotides enhances cell death when combined with ionizing radiation.

Area of Science:

  • Oncology
  • Molecular Biology
  • Radiotherapy

Background:

  • Anti-apoptotic Bcl-2 family proteins, like Bcl-2 and Bcl-x, influence cancer treatment sensitivity.
  • The role of Mcl-1 (myeloid cell leukemia 1) in tumor cell response to ionizing radiation (IR) was previously unknown.

Purpose of the Study:

  • To investigate the relationship between Mcl-1 expression and the radioresponse of human melanoma cells.
  • To determine if Mcl-1 plays a role in radioresistance.

Main Methods:

  • Human melanoma cells were treated with Mcl-1 antisense oligonucleotides (ASOs) and IR.
  • Evaluated effects on proliferation, apoptosis, and clonogenic cell death.

Main Results:

  • Combined ASO treatment and IR reduced cell numbers 9.5-fold, significantly more than ASO or IR alone.
  • Apoptosis increased to 49% in combined treatment groups versus controls.
  • Colony formation assays showed a synergistic effect between Mcl-1 down-regulation and IR.

Conclusions:

  • Mcl-1 expression significantly impacts the radioresistance of human melanoma cells.
  • Targeting Mcl-1 may enhance the efficacy of radiotherapy for melanoma.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...